ANCA positivity at the time of renal biopsy is associated with chronicity index of lupus nephritis

被引:15
作者
Pyo, Jung Yoon [1 ]
Jung, Seung Min [2 ]
Song, Jason Jungsik [2 ]
Park, Yong-Beom [2 ,3 ]
Lee, Sang-Won [2 ,3 ]
机构
[1] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Rheumatol, Wonju, South Korea
[2] Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, 50-1 Yonsei Ro, Seoul 03722, South Korea
[3] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Systemic lupus erythematosus; Lupus nephritis; Antineutrophil cytoplasmic antibody; Histology; Prognosis; CLASSIFICATION; ERYTHEMATOSUS; GLOMERULONEPHRITIS; VASCULITIS; FEATURES; CRITERIA;
D O I
10.1007/s00296-019-04263-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the association of antineutrophil cytoplasmic antibody (ANCA) positivity with lupus nephritis (LN) activity, histological features and prognosis in Korean patients with biopsy-proven LN having the results of both myeloperoxidase (MPO-ANCA) and proteinase 3 (PR3)-ANCA. We retrospectively reviewed the medical records of 91 LN patients having the results of ANCA. We divided patients with LN into the two groups according to the ANCA positivity. We collected clinical and laboratory data at kidney biopsy and histological features such as LN class including class I, II, III, IV-S, IV-G and V, and activity and chronicity index. We evaluated prognosis of LN during the follow-up by death and kidney failure. Twelve of 91 patients (13.2%) had ANCA at kidney biopsy. There were no differences in demographic data, comorbidities, reasons for kidney biopsy and laboratory data at kidney biopsy between patients with and without ANCA. In 12 LN patients with ANCA, Class III was the most frequently observed LN class (41.7%), while in 79 LN patients without ANCA, class IV-G was the most often detected LN class (35.4%). There were no meaningful differences in classes of LN between the two groups. On the other hand, patients with ANCA exhibited the higher median chronicity index than those without (2.5 vs. 1.0, P=0.028), unlike activity index. ANCA positivity exhibited no association with death or kidney failure during the follow-up. ANCA positivity at kidney biopsy is associated with chronicity index of LN.
引用
收藏
页码:879 / 884
页数:6
相关论文
共 23 条
[11]   Can an Increase in Antineutrophil Cytoplasmic Autoantibody Titer Predict Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis? [J].
Koh, Jung Hee ;
Kemna, Michael Joseph ;
Tervaert, Jan Willem Cohen ;
Kim, Wan-Uk .
ARTHRITIS & RHEUMATOLOGY, 2016, 68 (07) :1571-1573
[12]   Pathology of lupus nephritis [J].
Lewis, E ;
Schwartz, MM .
LUPUS, 2005, 14 (01) :31-38
[13]   Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study [J].
Li, Cui ;
Zhou, Min-Lin ;
Liang, Dan-Dan ;
Wang, Jing-Jing ;
Yang, Jing ;
Zeng, Cai-Hong ;
Liu, Zhi-Hong ;
Zhang, Hai-Tao .
BMJ OPEN, 2017, 7 (07)
[14]   THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY 1990 CRITERIA FOR THE CLASSIFICATION OF CHURG-STRAUSS-SYNDROME (ALLERGIC GRANULOMATOSIS AND ANGIITIS) [J].
MASI, AT ;
HUNDER, GG ;
LIE, JT ;
MICHEL, BA ;
BLOCH, DA ;
AREND, WP ;
CALABRESE, LH ;
EDWORTHY, SM ;
FAUCI, AS ;
LEAVITT, RY ;
LIGHTFOOT, RW ;
MCSHANE, DJ ;
MILLS, JA ;
STEVENS, MB ;
WALLACE, SL ;
ZVAIFLER, NJ .
ARTHRITIS AND RHEUMATISM, 1990, 33 (08) :1094-1100
[15]   Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity [J].
Nasr, Samih H. ;
D'Agati, Vivette D. ;
Park, Hye-Ran ;
Sterman, Paul L. ;
Goyzueta, Juan D. ;
Dressler, Robert M. ;
Hazlett, Shawn M. ;
Pursell, Robert N. ;
Caputo, Christopher ;
Markowitz, Glen S. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (03) :682-690
[16]   CONTRIBUTION OF RENAL BIOPSY DATA IN PREDICTING OUTCOME IN LUPUS NEPHRITIS - ANALYSIS OF 116 PATIENTS [J].
NOSSENT, HC ;
HENZENLOGMANS, SC ;
VROOM, TM ;
BERDEN, JHM ;
SWAAK, TJG .
ARTHRITIS AND RHEUMATISM, 1990, 33 (07) :970-977
[17]   Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions [J].
Ortega, L. M. ;
Schultz, D. R. ;
Lenz, O. ;
Pardo, V. ;
Contreras, G. N. .
LUPUS, 2010, 19 (05) :557-574
[18]   Treatment of proliferative lupus nephritis: a slowly changing landscape [J].
Tesar, Vladimir ;
Hruskova, Zdenka .
NATURE REVIEWS NEPHROLOGY, 2011, 7 (02) :96-109
[19]   Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy [J].
Turner-Stokes, Tabitha ;
Wilson, Hannah R. ;
Morreale, Massimiliano ;
Nunes, Ana ;
Cairns, Tom ;
Cook, H. Terence ;
Pusey, Charles D. ;
Tarzi, Ruth M. ;
Lightstone, Liz .
KIDNEY INTERNATIONAL, 2017, 92 (05) :1223-1231
[20]   Treat-to-target in systemic lupus erythematosus: recommendations from an international task force [J].
van Vollenhoven, Ronald F. ;
Mosca, Marta ;
Bertsias, George ;
Isenberg, David ;
Kuhn, Annegret ;
Lerstrom, Kirsten ;
Aringer, Martin ;
Bootsma, Hendrika ;
Boumpas, Dimitrios ;
Bruce, Ian N. ;
Cervera, Ricard ;
Clarke, Ann ;
Costedoat-Chalumeau, Nathalie ;
Czirjak, Laszlo ;
Derksen, Ronald ;
Doerner, Thomas ;
Gordon, Caroline ;
Graninger, Winfried ;
Houssiau, Frederic ;
Inanc, Murat ;
Jacobsen, Soren ;
Jayne, David ;
Jedryka-Goral, Anna ;
Levitsky, Adrian ;
Levy, Roger ;
Mariette, Xavier ;
Morand, Eric ;
Navarra, Sandra ;
Neumann, Irmgard ;
Rahman, Anisur ;
Rovensky, Jozef ;
Smolen, Josef ;
Vasconcelos, Carlos ;
Voskuyl, Alexandre ;
Voss, Anne ;
Zakharova, Helena ;
Zoma, Asad ;
Schneider, Matthias .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) :958-967